Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

28 Sep 2005 07:02

Quintessentially English PLC28 September 2005 Quintessentially English PLC ('Quintessentially English' or the 'Company') Interim Results The Company announces its interim results for the six month period to 30th June2005. There was a turnover of £Nil, and a loss after tax of £56,283. No directorsreceived any remuneration during the period. No dividend is recommended. Since the Company's successful Admission to AIM in March 2004, the Company hasevaluated a number of potential investments and continues to do so. Costs include fees incurred in respect of a particular transaction which in theevent was aborted during due diligence. For further information: Quintessentially English PLCMr Michael Gurner, 07768 231 731 Profit and Loss AccountFor the period 01/01/05 to 30/06/05 Note Period Ended 30/06/2005 (unaudited) £ Turnover -Administrative expenses (60,633) ------------Operating Loss (60,633)Interest Receivable 4,382Interest Payable (32) ------------Loss on ordinary activities before taxation 1 (56,283)Taxation - ------------Loss on ordinary activities after taxation (56,283) ------------ Basic and diluted earnings per Ordinary share (pence)(0.50) ------------ Dividends per share (pence) 0 ------------ Balance Sheet As at 30/06/05 Note 30/06/2005 (unaudited) £ £ Fixed assets Investments 2 Current AssetsCash at bank and in hand 198,277Current LiabilitiesCreditors: Amounts falling due within one year (48,120) ------------Net current assets 150,157 -----------Total assets less current liabilities 150,159 ----------- Called up share capital 2 111,769Share premium 3 167,867Profit and loss account (129,477) -----------Equity shareholders funds 150,159 -----------Net assets per share (pence) 4 1.34p ----------- Cash Flow Statement For the period from 01/01/05 to 30/06/05 Note Period Ended 30/06/2005 (unaudited) £ Net cash inflow from operating activities (28,677) ----------- Returns on investment and servicing of finance:Interest received 4,382Interest payable (32) -----------Decrease in cash (24,327) ----------- Notes to the Interim Report 1. Loss on ordinary activities before taxation The loss for the period is representative of operational overheads incurred inthe period. 2. Called up share Capital The issued share capital compromises 11,176,865 ordinary shares of 1p each,consisting of 200 shares of 1p each issued as two £1 subscriber shares onincorporation and converted into 1p shares on 23rd February 2004, 6,666,665ordinary shares of 1p each issued on 24th February 2004 and 4,510,000 ordinaryshares of 1p each issued on 18th March 2004. 3. Share premium The share premium represents: £Premium arising on issues of ordinary shares in the period ended 31/12/2004 213,731Expenses of share issues in the period ending 31/12/2004 (45,864) -----------At 30th June 2005 167,867 ----------- 4. Net assets per share The calculation of net assets per share is based on the net assets at the end ofthe period of £150,159 and on the number of ordinary shares in issue(11,176,865) at 30th June 2005. 5. Preparation of Interim Report The interim financial information for the period from 1 January 2005 to 30thJune 2005 was approved by the directors on 19 September 2005. 6. Financial information The financial information in this statement does not constitute statutoryaccounts within the meaning of section 240 of the Companies Act 1985. 7. Availability Copies of the interim financial information for the period from 1 January 2005to 30th June 2005 are not being sent to shareholders. Copies will be availablefrom the Company's registered office, which is at 235 Old Marylebone Road,London NW1 50T. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Aug 20204:41 pmRNSSecond Price Monitoring Extn
7th Aug 20204:35 pmRNSPrice Monitoring Extension
30th Jul 20207:00 amRNSUpdate on progress of UK-Rapid Test Consortium
24th Jul 20209:45 amRNSExercise of Options and Total Voting Rights
23rd Jul 20202:05 pmRNSSecond Price Monitoring Extn
23rd Jul 20202:00 pmRNSPrice Monitoring Extension
23rd Jul 202012:45 pmRNSNotice of AGM and posting of Annual Report
21st Jul 20202:06 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202011:05 amRNSSecond Price Monitoring Extn
21st Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20209:05 amRNSSecond Price Monitoring Extn
21st Jul 20209:00 amRNSPrice Monitoring Extension
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
20th Jul 20202:00 pmRNSPrice Monitoring Extension
20th Jul 202011:45 amRNSInvestor presentation
20th Jul 202011:05 amRNSSecond Price Monitoring Extn
20th Jul 202011:00 amRNSPrice Monitoring Extension
16th Jul 20209:05 amRNSSecond Price Monitoring Extn
16th Jul 20209:00 amRNSPrice Monitoring Extension
15th Jul 20204:13 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSFinal Results
13th Jul 202011:39 amRNSHolding(s) in Company
10th Jul 202011:23 amRNSResult of General Meeting
10th Jul 20207:00 amRNSNotice of Results
8th Jul 20207:00 amRNSResult of Open Offer – full take up
2nd Jul 20207:08 amRNSApproval for sale in India
29th Jun 20202:06 pmRNSSecond Price Monitoring Extn
29th Jun 20202:00 pmRNSPrice Monitoring Extension
29th Jun 202010:08 amRNSHolding(s) in Company
29th Jun 20207:00 amRNSUpdate on progress of UK-Rapid Test Consortium
22nd Jun 20202:15 pmRNSPublication of Shareholder Circular
22nd Jun 20207:00 amRNSInvestor presentation
19th Jun 20209:32 amRNSFundraising to raise gross proceeds of up to £11m
9th Jun 20209:05 amRNSSecond Price Monitoring Extn
9th Jun 20209:00 amRNSPrice Monitoring Extension
9th Jun 20207:00 amRNSTrading Update
3rd Jun 20209:04 amRNSUpdate on progress of UK-Rapid Test Consortium
1st Jun 202012:31 pmRNSHolding(s) in Company
28th May 20202:47 pmRNSExercise of Options and TVR
28th May 20202:06 pmRNSSecond Price Monitoring Extn
28th May 20202:01 pmRNSPrice Monitoring Extension
27th May 20204:41 pmRNSSecond Price Monitoring Extn
27th May 20204:35 pmRNSPrice Monitoring Extension
27th May 20203:53 pmRNSStmnt re Share Price Movement
27th May 20202:06 pmRNSSecond Price Monitoring Extn
27th May 20202:00 pmRNSPrice Monitoring Extension
27th May 202011:05 amRNSSecond Price Monitoring Extn
27th May 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.